Enelbin retard 50 tablets 100mg Naftidrofurylum Энелбин

Enelbin (naftidrofuryl)

Enelbin contains the active ingredient naftidrofuryl, peripheral vasodilator.

Enelbin retard Indications

– violation of the peripheral circulation,

– including intermittent claudication,

– trophic ulcers,

– the initial stage of gangrene,

– diabetic angiopathy,

– Raynaud’s disease and syndrome,

– akrotsianoz,

– pain in the limbs at rest,

– paresthesia,

– cramps in the calf muscles.

– stroke, including cerebral insufficiency and cerebral atherosclerosis,

– behavioral disorders in the elderly,

– rehabilitation after stroke,

– acute stroke phase,

– post-coma and trauma,

– Meniere’s disease,

– ischemic damage to the retina and eye function,

– circulatory disorders of the inner ear.

Dosage & Administration

dose set individually depending on the nature and severity of the disease.
In case of violation of the peripheral circulation is usually administered inside of 100-200 mg 2-3 times a day. The maximum effect is achieved when administered at a daily dosage of 400-600 mg. The course of treatment – at least 3 months.

In the treatment of dementia and other conditions associated with impaired cerebral circulation, appoint 100 mg 3 times a day; in ischemic stroke – 200 mg three times daily or 300-400 mg 2 times a day. Therapy duration.
Tablets should be swallowed whole, without chewing, with a neutral fluid.

Contradictions

Hypersensitivity to naftidrofurilu or any other component of the drug, recent acute myocardial infarction, acute hemorrhagic stroke, severe heart failure (III-IV grade), severe coronary insufficiency, arrhythmia, a condition accompanied by bleeding, vascular collapse in history, marked hypotension , orthostatic regulation disturbances expressed by the human liver and kidney functions, pregnancy and lactation;

children up to age 14 years.

Browse more blood pressure available with international delivery.